Literature DB >> 12859285

Age, education and test performance on the Finnish CERAD.

M Karrasch1, M Laine.   

Abstract

OBJECTIVES: The purpose of this study was to clarify the effects of age and education on CERAD (Consortium to Establish a Registry for Alzheimer's Disease) test performances.
MATERIAL AND METHODS: We present preliminary data on CERAD test results for a sample of elderly normal Finns (n = 40, age 58-85 years).
RESULTS: Our results show no significant correlation between age and CERAD test results. Significant differences were found between subjects with low versus high education in nine CERAD test scores. The mean scores in the low-education group were near the cut-off point in the naming test, whereas the mean scores of the high-education group nearly reached the ceiling on six test scores. These differences were evident in the wordlist learning test, which has previously been argued to be unaffected by educational level. Savings scores were unaffected by education.
CONCLUSION: The results underline the importance of taking into account the educational level of persons with subjective memory complaints when screening with CERAD for mild cognitive impairment and preclinical Alzheimer's disease.

Entities:  

Mesh:

Year:  2003        PMID: 12859285     DOI: 10.1034/j.1600-0404.2003.00037.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Norms for CERAD constructional praxis recall.

Authors:  Gerda G Fillenbaum; Bruce M Burchett; Frederick W Unverzagt; Daniel F Rexroth; Kathleen Welsh-Bohmer
Journal:  Clin Neuropsychol       Date:  2011-10-13       Impact factor: 3.535

2.  Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

Authors:  Gerda G Fillenbaum; Gerald van Belle; John C Morris; Richard C Mohs; Suzanne S Mirra; Patricia C Davis; Pierre N Tariot; Jeremy M Silverman; Christopher M Clark; Kathleen A Welsh-Bohmer; Albert Heyman
Journal:  Alzheimers Dement       Date:  2008-03       Impact factor: 21.566

3.  Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study.

Authors:  Ilona Hallikainen; Anne M Koivisto; Teemu Paajanen; Asta Hiltunen; Pertti Karppi; Matti Vanhanen; Tarja Välimäki; Sanna-Kaisa Herukka; Hilkka Soininen; Tuomo Hänninen
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-05-05

4.  The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study.

Authors:  Ilona Hallikainen; Janne Martikainen; Pei-Jung Lin; Joshua T Cohen; Raquel Lahoz; Tarja Välimäki; Kristiina Hongisto; Saku Väätäinen; Matti Vanhanen; Peter J Neumann; Tuomo Hänninen; Anne Maria Koivisto
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-12-11

5.  Everyday cognition scales are related to cognitive function in the early stage of probable Alzheimer's disease and FDG-PET findings.

Authors:  Jung-Lung Hsu; Wen-Chuin Hsu; Chiung-Chih Chang; Kun-Ju Lin; Ing-Tsung Hsiao; Yen-Chun Fan; Chyi-Huey Bai
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

6.  Mild cognitive impairment: effect of education on the verbal and nonverbal tasks performance decline.

Authors:  Konstantinos Vadikolias; Anna Tsiakiri-Vatamidis; Grigorios Tripsianis; Georgios Tsivgoulis; Panagiotis Ioannidis; Aspasia Serdari; John Heliopoulos; Miltos Livaditis; Charitomeni Piperidou
Journal:  Brain Behav       Date:  2012-08-22       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.